Bills › 88th General Assembly
Relating to the regulation of medical cannabidiol, by altering the list of debilitating medical conditions and changing the definition of medical cannabidiol under the medical cannabidiol Act
Where it is now
- Done: IntroducedJanuary 22, 2019
- Done: SubcommitteeJanuary 23, 2019
- Stopped: Senate committeeDied when the General Assembly ended
- Next: Passes the Senate
- Next: House committee
- Next: Passes the House
- Next: To the Governor
- Next: Signed into law
Died when the session ended The 2020 session adjourned on June 14, 2020, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
This bill relates to the regulation of medical cannabidiol. The bill amends the definition of “debilitating medical condition” under the medical cannabidiol Act (Code chapter 124E) by removing the requirement that multiple sclerosis be accompanied by severe and persistent muscle spasms, replacing the term “untreatable pain” with “severe or chronic pain”, and including any medical condition for which a patient’s health care practitioner determines the use of medical cannabidiol could be medically beneficial.
Read the full explanation
The bill requires that any certification made by a health care practitioner for a patient for any medical condition not explicitly included on the list of debilitating medical conditions shall be made by a health care practitioner pursuant to reasonable medical evidence, in good faith, in the best interest of the patient, without fraudulent intent, and with the same reasonable medical judgment and prudence exercised according to generally accepted medical practice. Under current law, a health care practitioner may only issue a written certification for a debilitating medical condition explicitly included on the list of debilitating medical conditions. A written certification may be renewed on an annual basis if the health care practitioner determines that the patient continues to suffer from the debilitating medical condition. The bill alters the definition of medical cannabidiol by increasing the allowable tetrahydrocannabinol (THC) level in medical cannabidiol from no more than 3 percent to no more than 13 percent. The medical cannabidiol board retains the authority to recommend increasing the allowable THC level.
Senate subcommittee
Named January 23, 2019. On January 31, 2019 it recommended passage.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Iowa Code it changes
Lobbying
3 for · 3 against · 17 undecided · Who →
Similar bills
- HF 282 Relating to the regulation of medical cannabidiol, by altering the list of debilitating me…88th General Assembly · In committeeVery similar
Matched by wording or an identical title.